Genetic Susceptibility and Biomarkers of Platinum-Related Toxicities

L
Lawrence Einhorn, MD

Primary Investigator

M
Mary Brames

Primary Investigator

Overview

The purpose of this study is to look at the long term health of men who have been treated for a germ cell tumor with cisplatin chemotherapy.

Description

The purpose of this study is to look at the long term health of men who have been treated for a germ cell tumor with cisplatin chemotherapy.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Testicular Cancer
  • Age: Between 18 Years - 100 Years
  • Gender: Male

Inclusion Criteria
Diagnosed with testicular cancer
Diagnosed at age 49 or younger


Additional Information:
Participants may be paid for their participation.

Updated on 20 Nov 2022. Study ID: 1305011509 (RSRB45410)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center